Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment? [11]

AIDS

Volumn 13, Issue 13, 1999, Pages 1796-1797

  Jutte, A ^a   Schwenk, A ^a   Franzen, C ^a   Romer, K ^a   Diet, F ^a   Diehl, V ^a   Fatkenheuer, G ^a   Salzberger, B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIDANOSINE; INDINAVIR; LAMIVUDINE; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; CLINICAL ARTICLE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCOAGULABILITY; INCIDENCE; ISCHEMIC HEART DISEASE; LETTER; MALE; MORBIDITY; PRIORITY JOURNAL; RISK FACTOR;

ADULT; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0033390914     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199909100-00034     Document Type: Letter

References (15)